Esperion Therapeutics | ESPR - Ebit

Esperion Therapeutics reported $-42513000 in EBIT for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebit Change
Alnylam Pharmaceuticals ALNY:US USD -188614000 69.43M
Amarin AMRN:US USD 1.43M 39.05M
Amgen AMGN:US USD 2.23B 436M
Biogen BIIB:US USD 878.7M 6.6M
Biomarin Pharmaceutical BMRN:US USD -24500000 22.08M
Cytokinetics CYTK:US USD -127030000 18.59M
Daiichi Sankyo 4568:JP JPY 31.55B 29.65B
Eli Lilly And LLY:US USD 2.11B 169.2M
Esperion Therapeutics ESPR:US USD -42513000 890K
Halozyme Therapeutics HALO:US USD 75.91M 7.78M
Heron Therapeutics HRTX:US USD -20355000 21.53M
Intercept Pharmaceuticals ICPT:US USD -17985000 7.84M
Intra Cellular Therapies ITCI:US USD -47412000 8.22M
IONIS PHARMACEUT IONS:US USD -208019000 148.86M
Merk MRK:US USD 4.81B 725M
Minerva Neurosciences NERV:US USD -5069730 137.42K
Moderna Inc MRNA:US USD 1.58B 414M
Nektar Therapeutics NKTR:US USD -40889000 3.42M
Pfizer PFE:US USD 5.81B 3.89B
Ptc Therapeutics PTCT:US USD -166957000 98.77M
Puma Biotechnology PBYI:US USD 10.02M 7.62M
Regeneron Pharmaceuticals REGN:US USD 1.18B 46.9M
Sarepta Therapeutics SRPT:US USD -106833000 24.52M
Seattle Genetics SGEN:US USD -154004000 38.8M
United Therapeutics UTHR:US USD 186.8M 127.5M
Vanda Pharmaceuticals VNDA:US USD 6.63M 2.72M